Insight

While payment reductions under PAMA were delayed from 2021 to 2025, they are scheduled to resume on January 31, 2026

Digital health technologies continue to proliferate in the US, but unique reimbursement and market access challenges remain. The traditional medical device buy-and-bill purchasing model buoyed by payer reimbursement via standardized codes, fee schedules, and claims...